BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 26742514)

  • 1. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.
    Goold R; Flower M; Moss DH; Medway C; Wood-Kaczmar A; Andre R; Farshim P; Bates GP; Holmans P; Jones L; Tabrizi SJ
    Hum Mol Genet; 2019 Feb; 28(4):650-661. PubMed ID: 30358836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
    Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
    Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.
    Aldous SG; Smith EJ; Landles C; Osborne GF; Cañibano-Pico M; Nita IM; Phillips J; Zhang Y; Jin B; Hirst MB; Benn CL; Bond BC; Edelmann W; Greene JR; Bates GP
    Brain; 2024 May; 147(5):1784-1798. PubMed ID: 38387080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.
    Ament SA; Pearl JR; Grindeland A; St Claire J; Earls JC; Kovalenko M; Gillis T; Mysore J; Gusella JF; Lee JM; Kwak S; Howland D; Lee MY; Baxter D; Scherler K; Wang K; Geman D; Carroll JB; MacDonald ME; Carlson G; Wheeler VC; Price ND; Hood LE
    Hum Mol Genet; 2017 Mar; 26(5):913-922. PubMed ID: 28334820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Huntington's Disease.
    Ghosh R; Tabrizi SJ
    Adv Exp Med Biol; 2018; 1049():1-28. PubMed ID: 29427096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
    da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
    J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease.
    Bao YF; Li XY; Dong Y; Wu ZY
    J Mol Med (Berl); 2023 Jul; 101(7):869-876. PubMed ID: 37231148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.
    Petracca M; Di Tella S; Solito M; Zinzi P; Lo Monaco MR; Di Lazzaro G; Calabresi P; Silveri MC; Bentivoglio AR
    Eur J Neurol; 2022 Jul; 29(7):1940-1951. PubMed ID: 35357736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
    ;
    Cell; 2019 Aug; 178(4):887-900.e14. PubMed ID: 31398342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.
    Shin A; Shin B; Shin JW; Kim KH; Atwal RS; Hope JM; Gillis T; Leszyk JD; Shaffer SA; Lee R; Kwak S; MacDonald ME; Gusella JF; Seong IS; Lee JM
    Hum Mol Genet; 2017 Apr; 26(7):1258-1267. PubMed ID: 28165127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the Genetic and Molecular Features of Huntington's Disease in Northern Colombia.
    Ahmad M; Ríos-Anillo MR; Acosta-López JE; Cervantes-Henríquez ML; Martínez-Banfi M; Pineda-Alhucema W; Puentes-Rozo P; Sánchez-Barros C; Pinzón A; Patel HR; Vélez JI; Villarreal-Camacho JL; Pineda DA; Arcos-Burgos M; Sánchez-Rojas M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation.
    Ciosi M; Cumming SA; Chatzi A; Larson E; Tottey W; Lomeikaite V; Hamilton G; Wheeler VC; Pinto RM; Kwak S; Morton AJ; Monckton DG
    J Huntingtons Dis; 2021; 10(1):53-74. PubMed ID: 33579864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).
    Quaid KA; Eberly SW; Kayson-Rubin E; Oakes D; Shoulson I;
    Clin Genet; 2017 Jun; 91(6):824-831. PubMed ID: 27740685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Genetic Aspects of Huntington's Disease in the Malian Population.
    Bocoum A; Coulibaly T; Ouologuem M; Cissé L; Diallo SH; Maiga BB; Dembélé K; Diallo S; Coulibaly SDP; Kané F; Coulibaly T; Coulibaly D; Taméga A; Yalcouyé A; Diarra S; Dembélé ME; Maiga AB; Cissé CAK; Traoré O; Fischbeck KH; Guinto CO; Maiga Y; Landouré G;
    J Huntingtons Dis; 2022; 11(2):195-201. PubMed ID: 35311712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missing the pathological expansion in Huntington disease: de novo c.51C>G variant on the expanded allele causing intrafamilial allele dropout.
    Magri S; Nanetti L; Mongelli A; Rizzo E; Taroni F; Mariotti C; Gellera C
    Am J Med Genet A; 2021 Feb; 185(2):397-400. PubMed ID: 33247537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
    Dabrowska M; Ciolak A; Kozlowska E; Fiszer A; Olejniczak M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's Disease Pathogenesis: Two Sequential Components.
    Hong EP; MacDonald ME; Wheeler VC; Jones L; Holmans P; Orth M; Monckton DG; Long JD; Kwak S; Gusella JF; Lee JM
    J Huntingtons Dis; 2021; 10(1):35-51. PubMed ID: 33579862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.